Status:

COMPLETED

Synuclein-One Study

Lead Sponsor:

CND Life Sciences

Conditions:

Parkinson Disease

Multiple System Atrophy

Eligibility:

All Genders

40-99 years

Brief Summary

The Synuclein-One Study will be evaluating α-synuclein in patients with Parkinson's disease, Multiple System Atrophy, Dementia with Lewy bodies and Pure Autonomic Failure. Using a simple diagnostic te...

Detailed Description

Phosphorylated α-synuclein pathology in the diagnosis of synucleinopathies through qualitative and quantitative measurements of cutaneous phosphorylated α-synuclein in patients with Parkinson's diseas...

Eligibility Criteria

Inclusion

  • Male and female between 40-99 years of age
  • Prior clinical diagnosis of Parkinson's disease, Multiple System Atrophy, Dementia with Lewy bodies or Pure Autonomic Failure
  • Health Subjects, no history of clinical or symptoms suggestive with synucleinopathy

Exclusion

  • Clinical evidence of severe vascular disease (history of ulceration, poor wound healing, vascular claudication)
  • Clinically active coronary artery or cerebrovascular disease
  • Current smoker or alcoholism
  • History of allergic reaction to local anesthesia for skin biopsies
  • Use of blood thinners (aspirin or Plavix alone is allowed)
  • Significantly impaired wound healing or history of scarring or keloid formation
  • Healthy individuals or individuals with synucleinopathy is disease may be explained by other causes: recent history of encephalitis, Cortical dementia of Alzheimer's type, Whipple's disease, toxin exposure, repeated head injury and stepwise disease progression suggestive of vascular etiology

Key Trial Info

Start Date :

January 4 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 8 2023

Estimated Enrollment :

428 Patients enrolled

Trial Details

Trial ID

NCT04700722

Start Date

January 4 2021

End Date

November 8 2023

Last Update

January 3 2024

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

MD First Research

Chandler, Arizona, United States, 85286

2

CND Life Sciences

Phoenix, Arizona, United States, 85018

3

Movement Disorders Center of Arizona

Scottsdale, Arizona, United States, 85258

4

The Neuro Center

Carlsbad, California, United States, 92011